Image

Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population

Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

ICS (International Continence Society) recommendations published in 2017 recommend performing urodynamic examinations in the sitting or standing position. These recommendations are based on a review of the literature published in 2008, which has several limitations: heterogeneous populations, old and non-harmonized techniques, and very few neurological patients. It seems appropriate to focus on neurological patients and to examine the influence of position on the detection of detrusor overactivity in these patients.

The point here is to reexamine the ICS recommendations, which are not designed for neurological patients. Indeed, many patients suffering from Multiple Sclerosis (MS) or Parkinson's disease are unable to sit or stand for the duration of the urodynamic examination. The investigators would like to assess whether exploring sphincter disorders in the supine position is still interpretable.

This would enable us to define ICS good practice recommendations for a neurological population.

Description

1st consultation (selection - D-15):

  • Targeted questioning of disorders, completion of USP self-questionnaire, and UPDRS or EDSS scales as part of care.
  • Verification of ultrasound results (for men).
  • Schedule Urodynamic Assessment as part of treatment.
  • Verification of eligibility criteria
  • Partial information of the patient (or relative/guardian/guardian if applicable) to limit bias, and a period of reflection prior to the urodynamic test to collect consent.

On the day of the Urodynamic Assessment (D0):

  • Written, free and informed consent.
  • Data collection by a physician trained in the study,
  • Randomization of patient to determine starting position (lying or sitting) for urodynamic assessment (via CleanWeb).
  • Urodynamic assessment according to ICS recommendations, with constant filling speed over the 2 fillings (50 ml/min), water filling - Laborie machine - T-Doc system in both positions in the order defined by randomization, and printout of curves.
  • Entry of socio-demographic data.
  • Curves reread by a doctor who had not performed the examination and who did not know the patient or the starting position (single blind).
  • Completion of the paper file by the physician reading the curves, with the following data for position 1 and position 2:
  • Volume at B1 and B3 (in ml)
  • Basal bladder pressure (cm / H2O)
  • Occurrence of CNID or mictional reflex arc (diagnosis of detrusor overactivity)
  • Volume of leakage or 1st NIDC (Uninhibited Detrusor Contraction) (ml) or
  • Bladder pressure at leakage (cm / H2O)
  • Maximum bladder pressure (cm / H2O)
  • Paper data entry on Excel database by a trained investigator declared on the study

Eligibility

Inclusion Criteria:

  • Patient with MS or neurologically confirmed Parkinson's disease, with indication for urodynamic assessment - 1st assessment
  • Clinical overactive bladder syndrome with USP overactive bladder sub-score > or = 4 - Age ≥18 years
  • In men: no prostatic hypertrophy on ultrasonography
  • In women: no stress urinary incontinence (SUI); USP SUI subscore ≤ 2
  • Affiliated with a social security scheme (excluding AME).
  • Free and informed written consent

Exclusion Criteria:

  • Opposition to the performance of a Urodynamic exam as part of treatment

Study details
    Urodynamic Exam
    Neurologic Disorder

NCT05949567

Assistance Publique - Hôpitaux de Paris

18 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.